Rory Sheehan1, Afia Ali, Angela Hassiotis. 1. aMental Health Sciences Unit, University College London bCamden Learning Disabilities Service, London, UK.
Abstract
PURPOSE OF REVIEW: Dementia is emerging as a significant condition in the population with intellectual disability. This review is aimed at clinicians working in the field. We revisit what is known on the subject and expand on this with results from recent research. The emphasis of this review is on the clinical research rather than laboratory or molecular research. RECENT FINDINGS: Research has encompassed all aspects of dementia in intellectual disability, from epidemiology, assessment and diagnosis, through to management. There remains a lack of evidence concerning both pharmacological and nonpharmacological treatment of dementia in people with intellectual disability. Recent research has tended to focus on dementia in Down syndrome. SUMMARY: More research is necessary in order to translate improvements in the understanding of the neuropathology of intellectual disability and dementia into effective treatments. There is also a need to investigate the optimum environment in which to provide holistic care for individuals affected.
PURPOSE OF REVIEW: Dementia is emerging as a significant condition in the population with intellectual disability. This review is aimed at clinicians working in the field. We revisit what is known on the subject and expand on this with results from recent research. The emphasis of this review is on the clinical research rather than laboratory or molecular research. RECENT FINDINGS: Research has encompassed all aspects of dementia in intellectual disability, from epidemiology, assessment and diagnosis, through to management. There remains a lack of evidence concerning both pharmacological and nonpharmacological treatment of dementia in people with intellectual disability. Recent research has tended to focus on dementia in Down syndrome. SUMMARY: More research is necessary in order to translate improvements in the understanding of the neuropathology of intellectual disability and dementia into effective treatments. There is also a need to investigate the optimum environment in which to provide holistic care for individuals affected.
Authors: Jose Luis Olmos-Serrano; Hyo Jung Kang; William A Tyler; John C Silbereis; Feng Cheng; Ying Zhu; Mihovil Pletikos; Lucija Jankovic-Rapan; Nathan P Cramer; Zygmunt Galdzicki; Joseph Goodliffe; Alan Peters; Claire Sethares; Ivana Delalle; Jeffrey A Golden; Tarik F Haydar; Nenad Sestan Journal: Neuron Date: 2016-02-25 Impact factor: 17.173
Authors: Barbara J Strupp; Brian E Powers; Ramon Velazquez; Jessica A Ash; Christy M Kelley; Melissa J Alldred; Myla Strawderman; Marie A Caudill; Elliott J Mufson; Stephen D Ginsberg Journal: Curr Alzheimer Res Date: 2016 Impact factor: 3.498
Authors: Gurjinder Kaur; Ajay Sharma; Wenjin Xu; Scott Gerum; Melissa J Alldred; Shivakumar Subbanna; Balapal S Basavarajappa; Monika Pawlik; Masuo Ohno; Stephen D Ginsberg; Donald A Wilson; David N Guilfoyle; Efrat Levy Journal: J Neurosci Date: 2014-04-09 Impact factor: 6.167
Authors: Jian Yan; Stephen D Ginsberg; Brian Powers; Melissa J Alldred; Arthur Saltzman; Barbara J Strupp; Marie A Caudill Journal: FASEB J Date: 2014-06-24 Impact factor: 5.191